Andreas Kaubisch, MD, discusses the phase III REACH and REACH-2 trials in advanced hepatocellular carcinoma.
Andreas Kaubisch, MD
Advertisement
Articles by Andreas Kaubisch, MD
Andreas Kaubisch, MD, discusses available treatment options for hepatocellular carcinoma.
Advertisement
Latest Updated Articles
Dr. Kaubisch on Treatment Options for HCCNovember 1st 2019
Dr. Kaubisch on the REACH Trials in HCCNovember 20th 2019
Advertisement
Advertisement
Trending on OncLive
1
Ifinatamab Deruxtecan BLA Voluntarily Withdrawn in Previously Treated Extensive-Stage SCLC
2
Long-Term PERSEUS Data Confirm Durable PFS Benefit With D-VRd in Transplant-Eligible Newly Diagnosed Myeloma
3
Five Under 5: Top Oncology Videos for the Week of 9/20
4
FDA Grants Priority Review to Perioperative Durvalumab Plus Neoadjuvant Enfortumab Vedotin in MIBC
5